These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The possible teratogenic effect of levamisole treatment during pregnancy].
    Author: Kazy Z, Puchó E, Czeizel E.
    Journal: Orv Hetil; 2005 Dec 04; 146(49):2499-500. PubMed ID: 16398315.
    Abstract:
    The possible teratogenic effect of levamisole treatment during pregnancy. Levamisole (Decaris) is an anthelminthic agent. The teratogenic effect of levamisole was evaluated by the analysis of a large population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. The mean gestational age was somewhat longer after levamisole treatment (adjusted t = 1.04; p = 0.30) while the mean birth weight was nearly similar in the two study groups (adjusted t = 0.36; p = 0.72). This first controlled case-control epidemiological study does not indicate a higher rate of congenital abnormalities in children born to mothers who had received oral levamisole treatment during pregnancy.
    [Abstract] [Full Text] [Related] [New Search]